MK-1439 (ID: DG01286) Resistance Data of HIV
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Key Molecule: HIV1 Reverse transcriptase (HIV1 RT)
Resistant Disease Human immunodeficiency virus infection [ICD-11: 1C62.0]
Molecule Alteration
Alteration Patterns Alteration Types Resistance Mutation Total Point Scores Levels of Drug resistance base on the total point score Ref
p.Y188L
Missense mutation N.A. Resistance [1]
Resistant Drug MK-1439
Experimental Note Identified from the Human Clinical Data
In Vitro Model AIP KO MEF cells Skin Mus musculus (Mouse) CVCL_UJ02
MT4 cells Umbilical cord blood Homo sapiens (Human) CVCL_2632
Experiment for
Molecule Alteration
PCR
Mechanism Description The cyanochlorophenol moiety forms pai-pai stacking with Y188, and the Y188L substitution eliminates the pai-pai interactions and creates a clash with DOR; thus, the Y188L substitution confers significant resistance to DOR, suggesting that the pai-pai interactions between the residues are crucial for the binding of DOR to RT.
References
Ref 1 In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways .Antimicrob Agents Chemother. 2015 Jan;59(1):590-8. doi: 10.1128/AAC.04201-14. Epub 2014 Nov 10. 10.1128/AAC.04201-14

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.